If the message below is not displayed correctly please click here to view it in your browser.
View in browser Web version   Twitter icon Tweet   Forward icon Forward  

Modulight newsletter 3/2015

Modulight ML7710 speaks your language
Followed by stellar success – ML7710 speaks your language
Tampere, March 19, 2015 – Modulight, Inc., a leading biomedical laser manufacturer announced today ML7710 will soon be available in multiple languages. ML7710 can soon be available also in Arabic, Chinese, French, German, Japanese, and Russian variants. Modulight ML7710 has been certified and supports a wide range of indications and configurations. Medical CE and ETL markings are valid for all configurations ranging from 1–8 channels. Channels can be equipped with lasers at any wavelength between 400–2000nm to enable support for all PDT photosensitizers, and many laser surgery, photo disinfection and photo coagulation applications. ML7710 saves cost through reduced time-to-market for pharmas, and protects the hospital investment by being the most versatile medical laser in the world.

“Orders keep on accruing and we’ve won every single ranging with pharmas since ML7710 design was introduced”, says Seppo from @modulight and continues: “This proves our strategy and commitment to ease of use and patient safety in Oncology, Surgery and Photo disinfection applications.”

“I believe ML7710 brings PDT physicians to the next level of confidence. Having had the pleasure to participate to both the design, and onsite support of the lasers I’m confident to say that customers will see this as a major leap. It seems we’ve been able to build the product from the physicians' point of view. I think the key to this has been working with doctors and learning from them”, says Jukka-Pekka A. who is an application engineer at @modulight, visiting tens of clinics and hospitals every year.

Modulight has shipped tens of ML7710s in the pre-market phase to a number of customers, and is now accelerating the deliveries world-wide. Currently our customers are using ML7710 for the following indications: bile duct cancer, skin cancers and diseases, ENT (ear-nose-throat) cancer, neck & head cancer, lung cancer, and others.
Photodynamic therapy: oncologic horizons
Going to future means learning from the past – for this purpose we’ve chosen to promote the excellent review paper written by Dr. Allison from 21st Century Oncology. His paper titled “Photodynamic therapy: oncologic horizons” published in Future Oncol. (2014) 10(1), 123–142 outlines the past, present and the future in a very nice comprehensive manner. We trust you find it interesting review of the state of PDT.
Give us your feedback
We’re seeing our products make better life. We’d also like to enable others to hear those fantastic stories in Twitter, Youtube or by email. Please take a selfie video preferably showing also the Modulight product you like – and tell us what you like about it. Please share with us your 15-30 second story. We’d like to thank all those who do with small token of appreciation from Champagne, France.
View in browser   Web version   Twitter icon   Tweet   Forward icon   Forward  
Modulight, Inc. • Phone marketing@modulight.com   Phone +358 20 743 9000
© 2015 Modulight, Inc. All rights reserved.
Unsubscribe Modulight emails